Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
20 January 2012

IN THIS ISSUE
Epigenetics at Genentech
Takeda job cuts
Generics market
AstraZeneca and IMS

 
Genentech backs epigenetics
Constellation Pharmaceuticals has entered into a broad collaboration with Genentech, a member of the Roche group, to discover and develop innovative treatments based on epigenetics, which focuses on the identification of small  molecule inhibitors of protein activity. More...
 
Takeda to axe 2100 jobs in Europe
Takeda has announced “strategic measures to achieve efficiencies for long-term growth”, which includes cutting close to 3000 jobs, 2100 of which will come from Europe. More...
 
Global market boom for generic drugs
The generics market is poised to experience strong growth as key blockbuster products go off patent, but companies looking to benefit from this will have to be careful about the product segments they compete in, according to a report from Frost & Sullivan. More...
 
AstraZeneca and IMS Health announce data and research collaboration
AstraZeneca and IMS Health have announced a three-year collaboration to use real-world healthcare data from Europe to guide AstraZeneca’s discovery and clinical development programmes. More...
 
FDA recommends drug user fee programmes
The FDA has completed, and transmitted to Congress, its recommendations for three user fee programmes, including the fifth authorisation of the Prescription Drug User Fee Act and programmes for human generic drugs and biosimilar biological products. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
Key Topics:

Latest blog posts
Generic drug and biosimilar user fees gain transaction
A new way to share best practices
GSK in spotlight for alleged unethical trials
More blog posts

Latest articles
Assessing tablet sticking propensity
Inside USP: global harmonisation presents opportunities and challenges
All systems slow
More articles

Upcoming events
Informex (14–17 February | USA)
Pharmapack (15–16 February | France)
Global ManuCHEM Strategies 2012 (13–14 February | Germany)
More events

Products/Service Profiles
Sterilin

High quality pharmaceutical packaging products
Sterilin high quality plastic packaging products are ideal for storing and transporting a wide range of pharmaceutical products.
Read more

 
Survey
Is lyophilisation technology advancing fast enough to meet demands from manufacturers of increasingly sensitive biopharmaceutical products?
Yes 41%
 
No 59%

This week we would like to know...

What is the most important change that has influenced chemical API manufacturing during the past 10 years?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.